The Australian and Victorian state government has inked a $2 billion (US$1.4 billion) deal with U.S. pharmaceutical giant, Moderna, to build a new facility that will be capable of producing 100 million mRNA vaccine doses per year.
The Morrison government announced the deal on Dec. 14, as part of its strategy to shore up the country’s sovereign capability—against global supply chain issues—and for Australia to become a key vaccine supply hub for the region.
